Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

BACKGROUND: Allergen-specific immunotherapy represents the only disease-modifying treatment for allergic diseases. We and others have previously demonstrated that intralymphatic immunotherapy (ILIT), a less time-consuming alternative to conventional subcutaneous immunotherapy (SCIT), is safe and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hylander, Terese, Larsson, Olivia, Petersson-Westin, Ulla, Eriksson, Mia, Kumlien Georén, Susanna, Winqvist, Ola, Cardell, Lars-Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728811/
https://www.ncbi.nlm.nih.gov/pubmed/26817454
http://dx.doi.org/10.1186/s12931-016-0324-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728811/
https://www.ncbi.nlm.nih.gov/pubmed/26817454
http://dx.doi.org/10.1186/s12931-016-0324-9

Ejemplares similares